Allen Mooney & Barnes Investment Advisors LLC Trims Stock Holdings in CVS Health Co. (NYSE:CVS)

Allen Mooney & Barnes Investment Advisors LLC reduced its stake in CVS Health Co. (NYSE:CVSFree Report) by 2.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 128,849 shares of the pharmacy operator’s stock after selling 2,687 shares during the period. CVS Health makes up approximately 1.9% of Allen Mooney & Barnes Investment Advisors LLC’s portfolio, making the stock its 19th biggest position. Allen Mooney & Barnes Investment Advisors LLC’s holdings in CVS Health were worth $10,174,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Weik Capital Management grew its position in CVS Health by 0.7% in the 1st quarter. Weik Capital Management now owns 17,600 shares of the pharmacy operator’s stock valued at $1,781,000 after acquiring an additional 120 shares in the last quarter. FCA Corp TX grew its position in shares of CVS Health by 0.6% during the first quarter. FCA Corp TX now owns 20,109 shares of the pharmacy operator’s stock worth $2,035,000 after buying an additional 122 shares in the last quarter. Arvest Trust Co. N A boosted its holdings in CVS Health by 1.2% in the fourth quarter. Arvest Trust Co. N A now owns 11,157 shares of the pharmacy operator’s stock valued at $1,040,000 after purchasing an additional 131 shares in the last quarter. SOA Wealth Advisors LLC. boosted its holdings in CVS Health by 4.9% in the fourth quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock valued at $226,000 after purchasing an additional 133 shares in the last quarter. Finally, Apella Capital LLC boosted its holdings in CVS Health by 4.2% in the fourth quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock valued at $272,000 after purchasing an additional 136 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at CVS Health

In related news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the sale, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.25% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Leerink Partnrs reaffirmed an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. Barclays assumed coverage on CVS Health in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $78.00 price target for the company. Royal Bank of Canada lowered their price target on CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a report on Thursday, February 8th. StockNews.com cut CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Finally, SVB Leerink assumed coverage on CVS Health in a research note on Monday, February 26th. They issued an “outperform” rating and a $88.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus target price of $89.44.

Get Our Latest Analysis on CVS Health

CVS Health Trading Down 0.3 %

NYSE:CVS opened at $79.56 on Tuesday. The stock has a fifty day moving average price of $75.91 and a two-hundred day moving average price of $73.63. The stock has a market capitalization of $100.12 billion, a price-to-earnings ratio of 12.32, a PEG ratio of 1.05 and a beta of 0.52. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.86. CVS Health Co. has a 1 year low of $64.41 and a 1 year high of $83.25.

CVS Health (NYSE:CVSGet Free Report) last posted its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.11. The company had revenue of $93.81 billion for the quarter, compared to analyst estimates of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. CVS Health’s revenue was up 11.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.99 earnings per share. As a group, sell-side analysts anticipate that CVS Health Co. will post 8.33 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.34%. The ex-dividend date is Friday, April 19th. CVS Health’s payout ratio is currently 41.18%.

CVS Health Company Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Stories

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.